Tuan Zea Tan Selected Research

Tuberculosis (Tuberculoses)

1/2021

Doxycycline host-directed therapy in human pulmonary tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuan Zea Tan Research Topics

Disease

38	Neoplasms (Cancer) 10/2022 - 05/2014
12	Breast Neoplasms (Breast Cancer) 09/2021 - 05/2014
10	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 07/2013
7	Carcinoma (Carcinomatosis) 12/2020 - 01/2015
6	Neoplasm Metastasis (Metastasis) 04/2021 - 09/2014
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 12/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
3	Triple Negative Breast Neoplasms 09/2021 - 08/2014
3	Ovarian Epithelial Carcinoma 01/2021 - 11/2017
3	Colonic Neoplasms (Colon Cancer) 11/2016 - 01/2016
2	Fanconi Anemia (Fanconi's Anemia) 01/2022 - 01/2018
2	Genomic Instability 01/2022 - 01/2018
2	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2019
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Disease Progression 09/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Pathologic Processes 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Iron Overload 12/2020
1	Necrosis 12/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Adenoma (Adenomas) 01/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2015
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	CytokinesIBA 01/2022 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2014
3	ChromatinIBA 01/2021 - 01/2018
3	Biological ProductsIBA 01/2021 - 12/2014
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 12/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2017
2	Histone Deacetylase InhibitorsIBA 09/2021 - 01/2019
2	PPAR gammaIBA 09/2021 - 05/2014
2	VimentinIBA 03/2021 - 01/2015
2	PlatinumIBA 01/2021 - 12/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2016
2	Metalloproteases (Metalloproteinases)IBA 01/2021 - 09/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 11/2020
2	CateninsIBA 01/2020 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2019
2	Phenobarbital (Luminal)FDA Link 01/2019 - 09/2014
2	LigandsIBA 01/2017 - 05/2014
2	Messenger RNA (mRNA)IBA 04/2016 - 01/2016
2	Superoxide DismutaseIBA 01/2016 - 05/2014
2	Small Interfering RNA (siRNA)IBA 09/2015 - 07/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2022
1	TNF Receptor-Associated Factor 4IBA 10/2022
1	CarcinogensIBA 10/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	OsteopontinIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	PanobinostatIBA 09/2021
1	Rosiglitazone (Avandia)FDA Link 09/2021
1	SolutionsIBA 04/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2021
1	Therapeutic UsesIBA 02/2021
1	asoxime chloride (H16)IBA 01/2021
1	AntigensIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Rad51 RecombinaseIBA 01/2021
1	SulfurIBA 12/2020
1	Cysteine (L-Cysteine)FDA Link 12/2020
1	IronIBA 12/2020
1	Cytotoxins (Cytolysins)IBA 12/2020
1	sotorasibIBA 11/2020
1	ChemokinesIBA 10/2020
1	Cytoskeletal ProteinsIBA 01/2020
1	cannogenin thevetoside (peruvoside)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Axl Receptor Tyrosine KinaseIBA 01/2020
1	Eph Family Receptors (Eph Receptors)IBA 01/2020
1	Codon (Codons)IBA 01/2020
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 01/2020
1	trametinibIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2022 - 05/2014
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2014
2	Immunotherapy 04/2020 - 01/2017
1	Radiotherapy 01/2021
1	Transplantation 11/2020